ArticleEMBO molecular medicine2023

Disease modification and symptom relief in osteoarthritis using a mutated GCP-2/CXCL6 chemokine.

Sara Caxaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.